Keywords: عوامل هدفمند; NET; Biomarker; Imaging; Somatostatin analogues; Chemotherapy; PRRT; Targeted agents;
مقالات ISI عوامل هدفمند (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عوامل هدفمند; Neurologic complications; Neurotoxicity; Chemotherapy; Targeted agents; Immunotherapy;
Keywords: عوامل هدفمند; Cáncer colorrectal; Quimioterapia; Colonoscopia; Agentes biológicos; Colorectal cancer; Chemotherapy; Colonoscopy; Targeted agents;
Keywords: عوامل هدفمند; Soft tissue sarcoma; systemic therapy; targeted agents;
Keywords: عوامل هدفمند; Cáncer de páncreas; Colangiocarcinoma; Tratamiento; Diagnóstico; Colorectal cancer; Chemotherapy; Colonoscopy; Targeted agents;
Keywords: عوامل هدفمند; Pancreatic cancer; FOLFIRINOX; Gemcitabine; Nab-paclitaxel; Targeted agents; Novel strategies;
Keywords: عوامل هدفمند; Chemotherapy; immunotherapy; lung cancer; non-curative therapy; radiation therapy; targeted agents;
Keywords: عوامل هدفمند; Limb Soft Tissue Sarcoma; Surgery; Preoperative radiotherapy; Combined modality treatment; Targeted agents; Chemotherapy;
Keywords: عوامل هدفمند; Cervix; Chemotherapy; Targeted agents; Recurrence;
Keywords: عوامل هدفمند; Pancreatic cancer; Metastatic disease; Gemcitabine; Nab-paclitaxel; FOLFIRINOX; Targeted agents; Immune therapy;
Keywords: عوامل هدفمند; Characterictics; Prognostic; Renal cell cancer; Surgery; Targeted agents;
Keywords: عوامل هدفمند; HSPs; Tumor biomarkers; Targeted agents; Personalized cancer medicine; HSP90;
Keywords: عوامل هدفمند; Cancer during pregnancy; Targeted agents; Biological agents; Monoclonal antibodies; Tyrosine kinase inhibitors; Malformation; Abortion; Safety
Keywords: عوامل هدفمند; Hepatocellular carcinoma; Systemic therapy; Targeted agents;
Keywords: عوامل هدفمند; Chemoprevention; Trials; Targeted agents
Keywords: عوامل هدفمند; Advanced gastric cancer; Chemotherapy; Immunotherapy; Molecular stratification; Targeted agents;
Keywords: عوامل هدفمند; acute myeloid leukemia; adjunct; AML; anthracycline; chemotherapy; consolidation; cytarabine; induction; non-transplant; targeted agents
Keywords: عوامل هدفمند; RECIST; Tumour assessment criteria; Targeted agents; FDG-PET; Advanced MR techniques;
Keywords: عوامل هدفمند; NSCLC; window-of-opportunity trials; targeted agents; neoadjuvant; thoracic malignancies
Keywords: عوامل هدفمند; Chemotherapy; Radiotherapy; Review; Stereotactic radiosurgery; Targeted agents
Keywords: عوامل هدفمند; Vulvar cancer; Chemotherapy; Systemic therapy; Targeted agents; Chemoradiation;
Keywords: عوامل هدفمند; Small cell lung cancer; Chemotherapy; Radiotherapy; Targeted agents; Immunomodulators
Keywords: عوامل هدفمند; Breast cancer; Protein kinases; HER2; PI3K-mTOR; Targeted agents;
Dual blockade of PI3K and MEK in combination with radiation in head and neck cancer
Keywords: عوامل هدفمند; Head and neck cancer; Radiation; Targeted agents; Xenografts; Growth delay;
Les patients avec indice de performance supérieur à 1
Keywords: عوامل هدفمند; Indice de performance; Néoplasmes pulmonaires; Chimiothérapie; Immunothérapie; Agents ciblés; Performance status; Lung neoplasms; Chemotherapy; Immunotherapy; Targeted agents;
Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study
Keywords: عوامل هدفمند; Antiangiogenic therapy; Brain metastasis; Targeted agents; Triple-negative status; VEGFR-2;
Rectal cancer: Neoadjuvant chemoradiotherapy
Keywords: عوامل هدفمند; Rectal cancer; Chemoradiotherapy; Induction and consolidation chemotherapy; Organ preservation; Targeted agents; Novel trials
Targeted agents in GI radiotherapy: Clinical efficacy and side effects
Keywords: عوامل هدفمند; Targeted agents; Gastrointestinal; Radiotherapy; Efficacy; Toxicity
Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database
Keywords: عوامل هدفمند; Renal cell cancer; Nephrectomy; Disease recurrence; Adjuvant therapy; Phase-3-trials; Targeted agents;
Sunitinib as a paradigm for tyrosine kinase inhibitor development for renal cell carcinoma
Keywords: عوامل هدفمند; Renal cell carcinoma; Sunitinib; Targeted agents
Decitabine and Sorafenib Therapy in FLT-3 ITD-Mutant Acute Myeloid Leukemia
Keywords: عوامل هدفمند; Combination therapy; FLT-3 inhibitors; Hypomethylating agents; Targeted agents;
Recent advances in the treatment of hormone receptor positive HER2 negative metastatic breast cancer
Keywords: عوامل هدفمند; Targeted agents; Metastatic breast cancer; Endocrine therapy; Endocrine resistance; Next generation sequencing technologies
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer
Keywords: عوامل هدفمند; Tumor metabolism; NAD; NAMPT; NAPRT1; Targeted agents; ATP; adenosine triphosphate; NA; nicotinic acid; NAD; nicotinamide adenine dinucleotide; (NAM); nicotinamide; NAMN; nicotinic acid mononucleotide; NAMPT; nicotinamide phosphoribosyltransferase; NAPRT1
Towards new methods for the determination of dose limiting toxicities and the assessment of the recommended dose for further studies of molecularly targeted agents – Dose-Limiting Toxicity and Toxicity Assessment Recommendation Group for Early Trials of T
Keywords: عوامل هدفمند; Phase 1; Targeted agents; Dose limiting toxicity; Maximum tolerated dose; Recommended phase 2 dose; Toxicities; Trial design
Will novel agents for ALL finally change the natural history?
Keywords: عوامل هدفمند; acute lymphoblastic leukemia; ALL; immunotherapy; CAR T cells; targeted agents
Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: How should we counsel cancer patients about breastfeeding?
Keywords: عوامل هدفمند; Chemotherapy; Targeted agents; Antiemetics; Growth factors; Breastfeeding; Milk; Pharmacokinetics; Cancer
Current and future systemic treatments for renal cell carcinoma
Keywords: عوامل هدفمند; Renal cell carcinoma; Metastatic; VEGF; mTOR; Targeted agents
Targeted Agent Use in Cancer Patients at the End of Life
Keywords: عوامل هدفمند; Antineoplastic agents; end of life; palliative care; quality of care; supportive care; targeted agents
Medical treatment of advanced non-small cell lung cancer in elderly patients: A review of the role of chemotherapy and targeted agents
Keywords: عوامل هدفمند; Non-small cell lung cancer; Elderly; Chemotherapy; Targeted agents; Medical treatment
Targeted Therapy and New Anticancer Drugs in Advanced Disease
Keywords: عوامل هدفمند; Targeted agents; Non-small cell lung cancer; Advanced lung cancer; Small cell lung cancer;
Radical treatment of non-small cell lung cancer during the last 5 years
Keywords: عوامل هدفمند; Lung cancer; Staging; Morbidity; Mortality; TNM classification; Surgery; Radiotherapy; Chemotherapy; Targeted agents; Quality of life
Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLC
Keywords: عوامل هدفمند; NSCLC; Tyrosine kinase inhibitors; Erlotinib; Gefitinib; Targeted agents; Mutations; Resistance
The Management of Early-Stage and Metastatic Triple-Negative Breast Cancer
Keywords: عوامل هدفمند; Breast cancer; Triple negative; Chemotherapy; Targeted agents; Radiation; BRCA mutation;
Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube
Keywords: عوامل هدفمند; Ovarian cancer; Targeted agents; Clinical trials
Epidemiologic Trends in Renal Cell Carcinoma in the Cytokine and Post-Cytokine Eras: A Registry Analysis of 28,252 Patients
Keywords: عوامل هدفمند; Cytokines; Distant disease; Regional disease; Renal cell cancer; Targeted agents
Management of Favorable-Risk Patients With Metastatic Renal Cell Carcinoma: When to Start and When to Stop Targeted Therapy
Keywords: عوامل هدفمند; Active surveillance; Commencing therapy; Monitoring; Stopping therapy; Targeted agents
Multidisciplinary management of metastatic renal cell carcinoma in the era of targeted therapies
Keywords: عوامل هدفمند; Renal cell carcinoma; Targeted agents; Multidisciplinary management
Targeted (and chemotherapeutic) agents as maintenance treatment in patients with metastatic non-small-cell lung cancer: Current status and future challenges
Keywords: عوامل هدفمند; NSCLC; Maintenance; Tyrosine kinase inhibitors; Bevacizumab; Targeted agents; Erlotinib; Gefitinib; Molecular targeted therapy;
Overcoming resistance to tyrosine kinase inhibitors in renal cell carcinoma
Keywords: عوامل هدفمند; Tyrosine kinase inhibitors; Sunitinib; Metastatic renal cell carcinoma; Resistance; Targeted agents
New drugs for breast cancer subtypes: Targeting driver pathways to overcome resistance
Keywords: عوامل هدفمند; Breast cancer subtypes; Molecular classification; Targeted agents